Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-14

FDA Approved: HERZUMA — Original Application (Cephalon, Inc.)

View source ↗

Summary

FDA approved Herzuma (trastuzumab) through an original Biologics License Application, establishing it as a biosimilar to trastuzumab for indications in HER2-pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HERZUMA (TRASTUZUMAB)

Snippet

ORIG AP for HERZUMA (TRASTUZUMAB)